A detailed history of Ameritas Investment Partners, Inc. transactions in Avita Medical, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 2,076 shares of RCEL stock, worth $26,614. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,076
Previous 2,076 -0.0%
Holding current value
$26,614
Previous $16,000 37.5%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$10.7 - $17.48 $22,213 - $36,288
2,076 New
2,076 $35,000
Q2 2022

Aug 12, 2022

SELL
$4.6 - $8.82 $8,611 - $16,511
-1,872 Closed
0 $0
Q2 2021

Aug 06, 2021

BUY
$17.23 - $22.02 $32,254 - $41,221
1,872 New
1,872 $38,000

Others Institutions Holding RCEL

About AVITA Medical, Inc.


  • Ticker RCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,030,900
  • Market Cap $321M
  • Description
  • AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...
More about RCEL
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.